PUBLICATIONS

Il CIAS sviluppa un'intensa attività di ricerca, anche a supporto di commesse pubbliche e private, provvedendo poi alla divulgazione internazionale dei risultati raggiunti, ove non coperti da segreto industriale o obblighi di riservatezza.

• 2022, Soffritti I, D’Accolti M, Cason C, Lanzoni L, Bisi M, Volta A, Campisciano G, Mazzacane S, Bini F, Mazziga E, Toscani P, Caselli E., Comar M. Introduction of probiotic-based sanitation in the emergency ward of a children hospital during COVID-19 pandemics. Infection and drug resistance 15:1399. DOI:10.2147/IDR.S356740.
• 2022, Bortolotti D, Gentili V, Bortoluzzi A, Govoni M, Schiuma G, Beltrami S, Rizzo S, Baldi E, Caselli E, Pugliatti M, Castellazzi M, Fernández M, Fainardi E, Rizzo R. Herpesvirus infections in KIR2DL2 positive multiple sclerosis patients: mechanisms triggering autoimmunity. Microorganisms, 10:494. DOI: 10.3390/microorganisms10030494.
• 2022, Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli E, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. Journal of Translational Medicine 20:111. DOI: 10.1186/s12967-022-03296-9.
• 2022, Rotondo JC, Martini F, Maritati M, Caselli E, Gallenga CE, Guarino M, De Giorgio R, Mazziotta C, Tramarin ML, Badiale G, Tognon M, Contini C. Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection. Microorganisms 10:1193. doi: 10.3390/microorganisms10061193.
• 2022, Soffritti I, D'Accolti M, Maccari C, Bini F, Mazziga E, de Conto F, Calderaro A, Arcangeletti MC, Caselli E. Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis. Microorganisms 10:1600. doi: 10.3390/microorganisms10081600.
• 2022, Cason C, D'Accolti M, Soffritti I, Mazzacane S, Comar M, Caselli E. Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance. Front Microbiol 13:969863. doi: 10.3389/fmicb.2022.969863.

• 2022, Coccagna, M., Manzella, F., Mazzacane, S., Pagliarini, G., Sciavicco, G. Statistical and Symbolic Neuroaesthetics Rules Extraction fromEEG Signals. In: Ferrández Vicente, J.M., Álvarez-Sánchez, J.R., de la Paz López, F., Adeli, H. (eds) Artificial Intelligence in Neuroscience: Affective Analysis and Health Applications. IWINAC 2022. Lecture Notes in Computer Science, vol 13258. Springer, Cham. https://doi.org/10.1007/978-3-031-06242-1_53

• 2021, Soffritti I, D’Accolti M, Ravegnini G, Arcangeletti MC, Maccari C, De Conto F, Calderaro A, Caselli E. Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 infection in human dermal fibroblasts: possible significance in the induction of fibrosis in systemic sclerosis. Cells 10:1060. DOI: 10.3390/cells10051060.
• 2021, D’Accolti M, Soffritti I, Mazzacane S, Caselli E. Bacteriophages as a Potential 360-Degree Pathogen Control Strategy. Microorganisms 9:261. DOI: 10.3390/microorganisms9020261.
• Cason C, D’Accolti M, Campisciano G, Soffritti I, Ponis G, Mazzacane S, Maggiore A, Risso FM, Comar M, Caselli E. Microbial Contamination in Hospital Environment Has the Potential to Colonize Preterm Newborns’ Nasal Cavities. Pathogens 10:615. DOI: 10.3390/pathogens10050615.
• 2021, Soffritti I, D’Accolti M, Fabbri C, Passaro A, Manfredini R, Zuliani G, Libanore M, Franchi M, Contini C, Caselli E. Oral microbiome dysbiosis is associated with symptoms severity and local immune/inflammatory response in COVID-19 patients: a cross-sectional study. Frontiers in Microbiology 12:687513. DOI: 10.3389/fmicb.2021.687513.
• 2021, D’Accolti M, Roncati M, Soffritti I, Siciliani G, Caselli E. Scrubbing Wipes to Dislodge Dental Biofilm Can Remove and Inactivate Viruses from Tooth Surface: Perspectives for Covid-19 Prevention. Biomedical Journal of Scientific &Technical Research 37:29592. DOI: 10.26717/BJSTR.2021.37.006028.
• 2021, Ferri C, Arcangeletti M-C, Caselli E, Zakrewska K, Maccari C, Calderaro A, D’Accolti M, Soffritti I, Arvia R, Sighinolfi G, Artoni E, Giuggioli D. Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis. Journal of Autoimmunity 124:102727. DOI: 10.1016/j.jaut.2021.102727.
• 2021, D’Accolti M, Soffritti I, Bonfante F, Ricciardi W, Mazzacane S, Caselli E. Potential of an Eco‐Sustainable Probiotic‐Cleaning Formulation in Reducing Infectivity of Enveloped Viruses. Viruses 13:2227. DOI: 10.3390/v13112227.
• 2022, D’Accolti M, Soffritti I, Bini F, Mazziga E, Mazzacane S, Caselli E. Pathogen Control in the Built Environment: A Probiotic-Based System as a Remedy for the Spread of Antibiotic Resistance. Microorganisms 10:225. DOI: 10.3390/microorganisms10020225.
• 2020, Caselli E, Fabbri C, D’Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M. Defining the oral microbiome by Whole-Genome Sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiology 20:120, DOI: 10.1186/s12866-020-01801-y.
• 2020, Tarricone R, Rognoni C, Arnoldo L, Mazzacane S, Caselli E. A Probiotic-Based Sanitation System for the Reduction of Healthcare Associated Infections and Antimicrobial Resistances: A Budget Impact Analysis. Pathogens 9:502, DOI: 10.3390/pathogens9060502.
• 2020, De Giorgi A, Fabbian F, Di Simone E, Greco S, De Giorgio R, Zuliani G, Passaro A, Caselli E, Manfredini R, Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy. Eur Rev Med Pharmacol Sci 24:8219-8225. DOI: 10.26355/eurrev_202008_22511.
• 2020, Contini C, Caselli E, Maritati M, Martini F, Torreggiani E, Seraceni S, Vesce F, Perri P, Rizzo L, Tognon M (2020). COVID-19 is a multifaceted challenging pandemic which needs urgent public health interventions. Microorganisms 8:1228. DOI: 10.3390/microorganisms8081228.
• 2020, Caselli E, Purificato I. Could we fight healthcare-associated infections and antimicrobial resistance with probiotic-based sanitation? Annali dell’Istituto Superiore di Sanità 56(3), 263-266. DOI: 10.4415/ANN_20_03_03.
• 2020, D’Accolti M, Soffritti I, Passaro A, Zuliani G, Antonioli P, Mazzacane S, Manfredini R, Caselli E. SARS-CoV-2 RNA contamination on surfaces of a Covid-19 ward in a hospital of northern Italy: what risk of transmission? Eur Rev Med Pharmacol Sci 24(17): 9202-9207. DOI: 10.26355/eurrev_202009_22872.
• 2020, Arcangeletti MC, D’Accolti M, Maccari C, Soffritti I, De Conto F, Chezzi C, Calderaro A, Ferri C, Caselli E. Impact of human cytomegalovirus and human herpesvirus 6 infection on the expression of factors associated with cell fibrosis and apoptosis: clues for implication in systemic sclerosis development. International Journal of Molecular Sciences 21(17):6397. DOI: 10.3390/ijms21176397.
• 2020, Caselli E, D’Accolti M, Santi E, Soffritti I, Conzadori S, Mazzacane S, Greco P, Contini C, Bonaccorsi G. Vaginal microbiota and chemokine microenvironment in HPV clearance/persistence in women surgically treated for cervical intraepithelial neoplasia: an observational prospective study. Frontiers in Cellular and Infection Microbiology 10:540900. DOI: 10.3389/fcimb.2020.540900.
• 2020, Caselli E, Soffritti I, Lamberti G, D’Accolti M, Franco F, Demaria D, Contoli M, Passaro A, Contini C, Perri P. Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients. Biology 9(11): 374. DOI: 10.3390/biology9110374.
• 2020, Caselli E, D’Accolti M, Caccuri F, Soffritti I, Gentili V, Bortolotti D, Rotola A, Cassai E, Fiorentini S, Zani A, Caruso A, Rizzo R, Di Luca D. The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions. Cells 9:2608. DOI: doi.org/10.3390/cells9122608.
• 2020, Coccagna M, Avanzini P, Portera M, Vecchiato G, Fabbri Destro M, Sironi VA, Salvi F, Gatti A, Domenicali F, Folgieri R, Banzi A, Caselli E, Lanzoni L, Volta A, Bisi M, Cesari S, Vivarelli A, Balboni PG, Santangelo CG, Sassu G, Mazzacane S, Neuroaesthetics of Art Vision: an Experimental Approach to the Sense of Beauty, J Clin Trials 10:404. doi: 10.35248/2167-0870.20.10.404 (ISRCTN International Clinical Trials Registry, ISRCTN70216542)
• 2020, From Neuroaesthetics to Neuro-osmology in search of beauty.The relationship between odor perception and brain is a fascinating new field of study that will be explored by CIAS, Interdepartmental Research Centre of the University of Ferrara. Moellhausen spa.
• 2020, Caselli E, Soffritti I, D’Accolti M, Bortolotti D, Rizzo R, Sighinolfi G, Giuggioli D, Ferri C. HHV-6A infection and systemic sclerosis: clues of a possible association. Microorganisms 8:39, doi:10.3390/microorganisms8010039, IF= 4.167
• 2020. Cesari S, Valdisseri P, Coccagna M, Mazzacane S, The Energy Saving Potential of Wide Windows in Hospital Patient Rooms, Optimizing the Type of Glazing and Lighting Control Strategy under Different Climatic Conditions. DOI:10.3390/en13082116. pp.1-24. ENERGIES, ISSN:1996-1073 vol. 13 (8)
• 2020, Impallaria A, Mazzacane S, Petrucci F, Tisato F, Volpe L. Portable X-ray fluorescence device reveals the artistic palette of Carlo Bononi, Baroque artist from Ferrara, X-Ray Spectrometry. 1–9.  John Wiley & Sons Ltd; https://onlinelibrary.wiley.com/doi/full/10.1002/xrs.3139
• 2020, Bortolotti D, Soffritti I, D’Accolti M, Gentili V, Di Luca D, Rizzo R, Caselli E. HHV-6A infection of endometrial epithelial cells affects miRNA expression and trophoblast cell attachment. Reproductive Sciences, doi: 10.1007/s43032-019-00102-8, IF = 2.559
• 2020, Bortolotti D, Gentili V, Caselli E, Sicolo M, Soffritti I, D’Accolti M, Barao I, Rotola A, Di Luca D, Rizzo R. DNA Sensors’ Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection. Frontiers in Microbiology 11:226. doi: 10.3389/fmicb.2020.00226. IF = 4.076
• 2020, Pegoraro A, Bortolotti D, Marci R, Caselli E, Falzoni S, De Marchi E, Di Virgilio F, Rizzo R, Adinolfi E. The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility. Frontiers in Pharmacology 11:96, doi: 10.3389/fphar.2020.00096, IF = 4.400
• 2019, Caselli E, Arnoldo L, Rognoni C, D’Accolti M, Soffritti I, Lanzoni L, Bisi, M, Volta A, Tarricone S, Brusaferro S, Mazzacane S. Impact of a microbial-based hospital sanitation on drug resistance, drug consumption and related costs: results of a multicentre study. Infection and Drug Resistance 12:501-510, IF = 3.443 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398408/pdf/idr-12-501.pdf 
• 2019, Lanzoni L., Mazzacane S. et al. Linea guida sulla valutazione del processo di sanificazione ambientale nelle strutture ospedaliere e territoriali per il controllo delle infezioni correlate all’assistenza (ICA), pubblicazione a cura di ANMDO (Associazione Nazionale dei Medici delle Direzioni Ospedaliere) e PSAF (Professionisti Sanitari Assicurativi e Forensi).
• 2019, De Cesare A, Caselli E, Lucchi A, Sala C, Parisi A, Manfreda G, Mazzacane S. Impact of a probiotic-based cleaning product on the microbiological profile of broiler litters and chicken caeca microbiota. Poultry Science 0:1-9, IF = 2.216 https://academic.oup.com/ps/article-abstract/98/9/3602/5429554?redirectedFrom=fulltext
• 2019, D’Accolti M, Soffritti I, Mazzacane S, Caselli E. Fighting AMR in the healthcare environment: microbiome-based sanitation approaches and monitoring tools. International Journal of Molecular Sciences 20:1535-1553, IF = 4.183 https://www.mdpi.com/1422-0067/20/7/1535
• 2019, D’Accolti M, Soffritti I, Lanzoni L, Bisi M, Volta A, Mazzacane S, Caselli E. Effective elimination of Staphylococcal contamination from hospital surfaces by a bacteriophage-probiotic sanitation strategy: a monocentric study. Microbial Biotechnology 12:742-751, IF = 3.340 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559196/pdf/MBT2-12-742.pdf
• 2019, Rizzo R, Bortolotti D, Gentili V, Rotola A, Bolzani S, Caselli E, Tola MR, Di Luca D. KIR2DS2/KIR2D2/HLA-C1 Haplotype is associated with Alzheimer’s disease: implication for the role of herpesvirus infections. Journal of Alzheimers Disease 67:1379-1389, IF = 3.920 https://content.iospress.com/articles/journal-of-alzheimers-disease/jad180777
• 2019, Caselli E, D’Accolti M, Soffritti I, Lanzoni L, Bisi M, Volta A, Berloco F, Mazzacane S. An innovative strategy for the effective reduction of MDR pathogens from the nosocomial environment. Advances in Microbiology, Infectious Diseases and Public Health 13:1-13, IF = 1.958 https://link.springer.com/chapter/10.1007%2F5584_2019_399
• 2019, Soffritti I, D’Accolti M, Lanzoni L, Volta A, Bisi M, Mazzacane S, Caselli E. The potential use of microorganisms as restorative agents: an update. Sustainability 11:3853, IF = 2.075 https://www.mdpi.com/2071-1050/11/14/3853
• 2019, Rognoni C, Brusaferro S, Caselli E, Arnoldo L, Pelissero G, La Fauci V, Antonioli P, Berloco F, Nola S, Trua N, Tognon L, Villone G, Coccagna M, D’Accolti M, Bisi M, Lanzoni L, Soffritti I, Volta A, Mazzacane S, Tarricone R. Controllo delle infezioni ospedaliere attraverso un sistema di sanificazione a base di probiotici: valutazione clinica ed economica. Mecosan 107:81-98, IF = 0.07 https://www.francoangeli.it/riviste/SchedaRivista.aspx?IDArticolo=64579&Tipo=Articolo%20PDF&idRivista=180
• 2019, Caselli E, Soffritti I, D’Accolti M, Piva I, Greco P, Bonaccorsi G. Atopobium vaginae and Porphyromonas somerae induce proinflammatory cytokines expression in endometrial cells: a possible implication for endometrial cancer? Cancer management and research 11:8571-8575, IF = 3.702 https://www.dovepress.com/atopobium-vaginae-and-porphyromonas-somerae-induce-proinflammatory-cyt-peer-reviewed-article-CMAR
• 2019, Bortolotti D, Gentili V, Rotola A, Caselli E, Rizzo R. HHV-6A infection induces amyloid-beta expression and activation of microglial cells. Alzheimer's Research & Therapy 11: 104 (IF =6.142) https://alzres.biomedcentral.com/articles/10.1186/s13195-019-0552-6
• 2019, Comar M, D’Accolti M, Cason C, Soffritti I, Campisciano G, Lanzoni L, Bisi M, Volta A, Mazzacane S, Caselli E. Introduction of NGS in environmental surveillance for Healthcare-associated infections control. Microorganisms 2019, 7(12), 708, IF = 4.167 https://www.mdpi.com/2076-2607/7/12/708
• 2019. Ferrante T, Tartaglia A, Coccagna M, Social, economic and environmental sustainability in planning community services. pp.87-94. in Lucarelli M.T, Mussinelli E, Daglio L, Leone MF (a cura di), Designing Resilience - ISBN:9788891635983
  
• 2019. Botti L, Caporale A, Coccagna M, Mora C, Ergonomics Principles for the Design of an Assembly Workstation for Left-Handed and Right-Handed Users. DOI:10.1007/978-3-030-20494-5_3. pp.27-39. In Advances in Manufacturing, Production Management and Process Control - ISBN:978-3-030-20493-8.... In ADVANCES IN INTELLIGENT SYSTEMS AND COMPUTING - ISSN:2194-5357 vol. 971
  
• 2018, Caselli E, Pancaldi S, Petrucci F, Impallaria A, Volpe L, D'Accolti M, Soffritti I, Coccagna M, Sassu G, Bevilacqua F, Volta A, Bisi M, Lanzoni L, Mazzacane S. Characterization of biodegradation in a 17th century easel painting and potential for a biological approach, PLOS One, December 5, https://doi.org/10.1371/journal.pone.0207630
• 2018, Caselli E, Arnoldo L, Rognoni C, D’Accolti M, Soffritti I, Lanzoni L, Bisi M, Volta A, Tarricone S, Brusaferro S, Mazzacane S. Impact of a microbial-based hospital sanitation on drug resistance and HAI-associated antimicrobial consumption and costs: a multi-center stud, Infection and Drug Resistance (accepted paper).
• 2018, Cesari S, Valdisseri P, Coccagna M, Mazzacane S. Energy savings in hospital patient rooms: the role of windows size and glazing properties, Energy Procedia, Volume 148/2018,1151-1158, ISSN 1876-6102; https://doi.org/10.1016/j.egypro.2018.08.027
• 2018, D'Accolti M, Soffritti I, Piffanelli M, Bisi M, Mazzacane S, Caselli E. Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents, Infection and Drug Resistance 11:1015-1026. doi: 10.2147/IDR.S170071
• 2018, Caselli E, D'Accolti M, Soffritti I, Piffanelli M, Mazzacane S. Spread of mcr-1 driven Colistin resistance on surfaces of Italian hospitals, Emerging infectious diseases, 24:1752-1753. doi: 10.3201/eid2409.171386
• 2018, Caselli E, Brusaferro S, Coccagna M, Arnoldo L, Berloco F, Antonioli P, Tarricone R, Pelissero G, Nola S, La Fauci V, Conte A, Tognon L, Villone G, Trua N, Mazzacane S, Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study (ISRCTN International Clinical Trials Registry, ISRCTN58986947), PLOS One, July 12, https://doi.org/10.1371/journal.pone.0199616
• 2018, Coccagna M, Cesari S, Valdisseri P, Romio P, Mazzacane S. Impact of morphological and functional features on hospitals’ energy consumption: A comparative analysis of six case studies,WSEAS Transactions on Environment and Development, Volume 14/2018 Art #2 212-225, E-ISSN: 2224-3496.
• 2017, Caselli E. Hygiene: microbial strategies to reduce pathogens anddrug resistance in clinical settings, Microbial Biotechnology (2017) 10(5), 1079–1083; https://doi.org/10.1111/1751-7915.12755
• 2017, Coccagna M, Cesari S, Valdisseri P, Romio P, Mazzacane S. Energy Consumption in Hospital Buildings: Functional and Morphological Evaluations of Six Case Studies, International Journal of Environmental Science, Vol.2/2017 443-452 , ISSN: 2367-8941.
• 2016, Caselli E, Berloco F, Tognon L, Villone 5, La Fauci V, Nola S, Antonioli P, Coccagna M, Balboni PG, Pelissero G, Tarricone R, Trua N, Brusaferro S, Mazzacane S and Study Group SAN-ICA. Influence of Sanitizing Methods on Healthcare-Associated Infections Onset: A Multicentre, Randomized, Controlled Pre-Post Interventional Study, Journal of Clinical Trials 2016, 6:5. DOI: 10.4172/2167-0870.1000285
• 2016, Caselli E, Coccagna M, Antonioli P, D'Accolti M, Lanzoni L, Camerada MT,  Balboni PG, Di Luca D, Mazzacane S. La rimodulazione del resistoma delle superfici ospedaliere: nuove prospettive di contrasto alle Infezioni Correlate all’Assistenza sanitaria ed ai fenomeni di antibiotico-resistenza, L’Ospedale, n.3, luglio-settembre 2016; pp. 60-67.
• 2016, Caselli E, D’Accolti M, Vandini A, Lanzoni L, Camerada MT, Coccagna M, Branchini A, Antonioli P,  Balboni PG, Di Luca D, Mazzacane S. Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation. PLoS ONE 2016, 11(2): e0148857. DOI:10.1371/journal.pone.0148857
• 2016, Caselli E, Antonioli P, Mazzacane S. Safety of probiotics used for hospital environmental sanitation. Journal of Hospital Infection, 94 (2016) 193-208; http://dx.doi.org/10.1016/j.jhin.2016.06.021
• 2016, Caselli E, Mazzacane S. Influence of sanitizing methods on healthcare associated infections: comparison between traditional and innovative probiotic-based approaches, Multicentre interventional study. DOI 10.1186/ISRCTN58986947.
• 2016, Caselli E, D'Accolti M, Antonioli P, Coccagna M, Di Luca D, Mazzacane S. Analysis of the resistome of the microbiota contaminating hospital surfaces: modulation by a sanitizing probiotic-based intervention, 44° Congresso Nazionale della Società Italiana di Microbiologia - SIM 2016,  Pisa 25-28 settembre 2016, p.32. http://www.societasim.it/documenti/sim2016-abstract-book.pdf
• 2016, Coccagna M. La gestione delle emergenze: relazione fra piani aziendali e rischi ambientali, in Sicurezza accessibile. La gestione dell’emergenza: coordinamento tra addetti aziendali e soccorritori esterni, EUT Edizioni Università di Trieste, ISBN 978-88-8303-727-6, pp. 19-58; http://hdl.handle.net/10077/12413
• 2015, La Fauci V, Costa GB, Anastasi F, Facciolà A, C. GO, Squeri R. An Innovative Approach to Hospital Sanitization Using Probiotics: In Vitro and Field Trials. Microbial & Biochemical Technology. 2015; 7 (3):5. doi: http://dx.doi.org/10.4172/1948-5948.1000198.
• 2015, Coccagna M. Key points of human awareness and emergency planning. schools as a case study, in Fikfak A, Vaništa Lazarević E, Fikfak N, Vukmirović M, Gabrijelčič P (editors). Places and Technologies 2015. Keeping up with technologies to make healthy places, University of Ljubljana, Faculty of Architecture, ISBN 9789616823685, pp.655-660
• 2014, Vandini A, Antonioli P, Lanzoni L, Camerada MT, Coccagna M, Branchini A, Leis M, Platano D, Caselli E, Balboni PG, Mazzacane S. La sanificazione delle degenze ospedaliere: nuove strategie a supporto della riduzione delle infezioni correlate all’assistenza sanitaria, L’Ospedale, 03/2014, pp.14-15.
• 2014, Vandini A, Frabetti A, Camerada MT, Lanzoni L, Mazzacane S, Balboni PG. Caratteristiche generali microbiologiche dell’ambiente nosocomiale, L’Ospedale, 03/2014, pp.24-29.
• 2014, Vandini A, Caselli E, Branchini A, Camerada MT, Lanzoni L, Platano D, Balboni PG, Mazzacane S. I probiotici: aspetti generali e valutazioni sulla sicurezza d’impiego, L’Ospedale, 03/2014, pp.32-45.
• 2014, Vandini A, Antonioli P, Lanzoni L, Camerada MT, Coccagna M, Branchini A, Platano D, Balboni PG, Mazzacane S. Il sistema di sanificazione PCHS Probiotic Cleaning Hygien System: risultati delle indagini sperimentali in vitro ed in campo, L’Ospedale, 03/2014, pp.48-62.
• 2014, Vandini A, Antonioli P, Lanzoni L, Camerada MT, Balboni PG, Coccagna M, Mazzacane S, Proposta di nuovi indicatori di igiene ambientale, L’Ospedale, 03/2014, pp.64-75.
• 2014, Vandini A, Frabetti A, Antonioli P, Platano D, Branchini A, et al., Reduction of the Microbiological Load on Hospital Surfaces Through Probiotic-Based Cleaning Procedures: A New Strategy to Control Nosocomial Infections. J Microbiol Exp 1(5): 00027. DOI: 10.15406/ jmen.2014.01.00027.
• 2014, Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 2014; 9(9):e108598. Epub 2014/09/ 27. doi: 10.1371/journal.pone.0108598 PONE-D-14-19956 [pii]. PMID: 25259528; PubMed Central PMCID: PMC4178175.
• 2014, Mazzacane S, Finzi G, Aparo L, Balboni PG, Vandini A, Antonioli P, Lanzoni L, Camerada MT, Coccagna M, Branchini A, Platano D. La sanificazione delle degenze ospedaliere: nuove strategie per la riduzione delle infezioni correlate all’assistenza sanitaria, L’Ospedale, 02/2014, pp.8-17.
• 2014, Costanzo S, Cusumano A, Giaconia C, Mazzacane S. A Proposed Methodology to Control Body Temperature in Patients at Risk of Hypothermia by means of Active Rewarming Systems. BioMed Research International, Volume 2014 (2014), Article ID 136407, 10 pp., http://dx.doi.org/10.1155/2014/136407.
• 2013, Fazio P, Granieri G, Casetta I, Cesnik E, Mazzacane S, Caliandro P, Pedrielli F, Granieri E. Gait measures with a triaxial accelerometer among patients with neurological impairment. Neurol Sci (2013) 34: 435. doi:10.1007/s10072-012-1017-x
• 2013, Mazzacane S, Balboni PG, Vandini A, Antonioli P. Igiene in sanità, innovazione e contenimento dei costi: il sistema innovativo PCHS, L’Ospedale, 02/2013, pp.30-35.
• 2012, Coccagna M (ed). Sicurezza e innovazione nelle strutture turistico-alberghiere. Prevenzione incendi, fruibilità e risparmio energetico, Unife Press (Ferrara), 196 pp.
• 2009, Frabetti A, Vandini A, Balboni PG, Triolo F, Mazzacane S. Experimental evaluation of the efficacy of sanitation procedures in operating rooms, American Journal of Infection Control, Volume 37, Issue 8, 658 - 664,
• https://doi.org/10.1016/j.ajic.2009.03.011

GESTIONE DEI DATI

Potrete rivolgervi al titolare del trattamento per esercitare i diritti previsti dall’art. 7 del D. lsg 196/03, come indicato nell'informativa completa disponibile a questo link: MODULO DI CONSENSO INFORMATO.

Titolare del trattamento dei dati è l'arch. Maddalena Coccagna del Centro di ricerca CIAS, Università degli Studi di Ferrara.